Lurbinectedin - Indication, Mechanism, Adverse Effects, and Precaution
Lurbinectedin is primarily used to treat the metastatic phase of small-cell lung cancer (SSLC). The article constitutes the drug in detail.
Dr. Rajesh Gulati
